FDA considers requiring co-prescribed antidote with opioids

Food and Drug Administration Commissioner Scott Gottlieb, M.D., said the FDA is considering whether opioid prescriptions should come with an antidote to treat overdoses. (Getty/BackyardProduction)

Should opioid prescriptions come with an antidote to treat overdoses?

The idea is being floated by Food and Drug Administration Commissioner Scott Gottlieb, M.D., who said he's seeking ways to increase access to naloxone and reduce deaths from opioid misuse.

The number of opioid overdose deaths reached 42,249 in 2016, double the 21,089 opioid-related deaths in 2010.

RELATED: Gottlieb: FDA needs to fill data gaps as it looks to increase access to targeted therapies

Gottlieb said the FDA also plans to discuss the potential development of over-the-counter naloxone at the upcoming meeting.

Suggested Articles

In a growing number of states, patients who get opioids may leave their doctors’ offices with prescription for naloxone, an overdose reversal drug.

Over 18 months, hospitals acquired 8,000 more medical practices and 14,000 more physicians left independent practice to become hospital employees.

Unsealed testimony in Optum’s lawsuit against a former employee reveals a new look at the secretive Amazon-led health venture’s plans.